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ABSTRACT
Objective To assess the feasibility, usability and
acceptability of two non-invasive, multiparameter,
continuous physiological monitoring (MCPM) technologies
for use in neonates within a resource-constrained
healthcare setting in sub-Saharan Africa.
Design A qualitative study using in-depth interviews
and direct observations to describe healthcare
professional and caregiver perspectives and experiences
with investigational MCPM technologies from
EarlySense and Sibel compared with selected reference
technologies.
Setting Pumwani Maternity Hospital is a public, high-
volume, tertiary hospital in Nairobi, Kenya.
Participants In-depth interviews were conducted with
five healthcare administrators, 12 healthcare providers
and 10 caregivers. Direct observations were made
of healthcare providers using the technologies on 12
neonates overall.
Results Design factors like non-invasiveness, portability,
ease-of-use and ability to measure multiple vital signs
concurrently emerged as key themes supporting
the usability and acceptability of the investigational
technologies. However, respondents also reported
feasibility challenges to implementation, including
overcrowding in the neonatal unit, lack of reliable access
to electricity and computers, and concerns about cost and
maintenance needs. To improve acceptability, respondents
highlighted the need for adequate staffing to appropriately
engage caregivers and dispel misconceptions about the
technologies.
Conclusion Study participants were positive about
the usefulness of the investigational technologies to
strengthen clinical care quality and identification of at-
risk neonates for better access to timely interventions.
These technologies have the potential to improve equity
of access to appropriate healthcare services and neonatal
outcomes in sub-Saharan African healthcare facilities.
However, health system strengthening is also critical to
support sustainable uptake of technologies into routine
care.
Trial registration number NCT03920761.

Strengths and limitations of this study
► We interviewed healthcare administrators, providers

and caregivers to understand the feasibility, usability and acceptability of investigational technologies
from multiple perspectives.
► The purposeful sampling design elicited a wide
range of perspectives although these cannot be used
to determine representative frequency of themes.
► The triangulation of direct observations with in-
depth interviews helped to strengthen reliability of
findings.
► The current study is compared with findings from
a previous study conducted at a private healthcare
facility in Nairobi, Kenya with the same technologies
and methodology to illuminate different implementation factors between private and public tertiary
hospitals.

BACKGROUND
Leading causes of neonatal deaths, including
35% due to preterm birth complications,
24% due to birth asphyxia and trauma, and
15% due to neonatal sepsis and infections,
are preventable with quality facility-
based
care.1 2 However, effective implementation
of evidence-
based neonatal interventions
may require monitoring of vital signs and
time-
sensitive clinical follow-
up, which may
be compromised in resource-
constrained
healthcare settings.3 4 Locally appropriate
technologies to support early detection of
physiologically unstable neonates requiring
timely intervention have the potential to
improve quality of care and neonatal health
outcomes.5
The Evaluation of Technologies for
Neonates in Africa (ETNA) platform aims
to boost development and optimisation of
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Qualitative study exploring the
feasibility, usability and acceptability of
neonatal continuous monitoring
technologies at a public tertiary hospital
in Nairobi, Kenya

Open access

METHODS
Study design and setting
depth interviews (IDIs) and direct
Comprised of in-
observations, this descriptive qualitative study elicited
perspectives and experiences of healthcare professionals
and caregivers around MCPM technology feasibility,
usability and acceptability. We evaluated the accuracy,
reliability and performance of novel MCPM technologies in comparison with verified reference technologies

Figure 1 Overview of the three multiparameter continuous
physiological monitoring technologies.
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(figure 1). Frequently used in hospitals worldwide, the
Masimo Rad-97 reference technology was selected based
on its capability for high-resolution data collection and
neonatal capnometry and pulse oximetry. We present
the findings based on the ‘Consolidated criteria for
Reporting Qualitative research’.7 8 The current study
used the following definitions9 10:
► Feasibility involved systemic factors required for implementation of MCPM technologies, such as hospital
infrastructure, operational capacities and functional
capacities of available healthcare providers (HCP).
► Usability involved design factors that influenced HCP
user experience, such as ease and efficiency of use,
frequency of errors, memorability to a casual user and
user satisfaction.
► Acceptability involved factors that influenced the willingness of healthcare administrators (HCA), HCP
and caregivers to use the technology.
PMH is a public, tertiary referral hospital serving
Nairobi, Kenya and is the largest referral maternity
hospital in sub-Saharan Africa with an average of 50–100
deliveries a day. Neonates in good health accompany their
mothers to the postnatal ward while neonates with health
complications are admitted to the neonatal unit, a large
hall separated into 11 cubicles representing different
diagnoses and care requirements. Neonates in more
critical health conditions are placed in cubicles closest
to the nursing station, while stable neonates awaiting
discharge are moved to cubicles on the other side of the
hall. Neonates commonly share cots and incubators with
up to four neonates in each. The neonatal unit is typically staffed by three nurses and three clinical officers or
physicians during the morning shift, and then two nurses
and one clinical officer or physician during the afternoon
and night shifts. The study moved between the different
cubicles within the neonatal unit and employed two dedicated study nurses to support the study. Caregiver visitation times are restricted to every 3 hours for the mothers
to breastfeed and care for the neonates.
Recruitment and data collection
A purposefully drawn study sample included HCA, direct
and indirect HCP and caregivers of neonates enrolled in
ETNA. Direct HCP consisted of ETNA study nurses who
were direct users of the MCPM technologies (HCP-D)
and indirect HCP included hospital physicians, nurses
and clinical staff involved in neonatal care but who did
not actively use the investigational or reference MCPM
technologies (HCP-I). Multiple MCPM technologies were
used with each neonate enrolled in ETNA during their
hospital stay. A sample size of five HCA, 12 HCP and 10
caregivers was estimated to reach data saturation covering
a wide range of perspectives from the healthcare staffing
positions and caregivers available.
Study recruitment was publicised using flyers and potential participants were approached in person by a member
of the qualitative study team, who introduced themselves and the ETNA study. To minimise bias, a Kenyan
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promising neonatal medical technologies to be used in
resource-constrained healthcare facilities. Understanding
user perspectives in the intended setting is critical to
medical technology design, development, deployment
and eventual uptake and acceptance. However, the feasibility, appropriateness and acceptability of novel technologies for improving maternal and neonatal health are
not often adequately investigated, thereby compromising
implementation efforts.6 The ETNA platform previously
conducted a qualitative evaluation of two novel, non-
invasive, multiparameter, continuous physiological monitoring (MCPM) technologies developed by EarlySense
and Sibel at Aga Khan University Hospital (AKUH), a
private, tertiary hospital in Nairobi, Kenya where MCPM
technologies were already used in neonatal intensive
care (Ginsburg et al 2021). By contrast, Pumwani Maternity Hospital (PMH) is a public, high-volume maternity
hospital in Nairobi where MCPM technologies are not
routinely used. In the current study, we assessed the feasibility, usability and acceptability of the same MCPM technologies at PMH to better understand the technologies’
use for neonates within a resource-constrained healthcare setting in sub-Saharan Africa.

Open access

Data analysis
IDIs were transcribed verbatim and translated into
English. Transcripts were uploaded into NVivo V.12 software (QSR International, Melbourne, Australia) for qualitative analysis following a thematic approach. Thematic
analysis involved becoming familiar with the data, generating initial codes collating identified codes into themes,
and describing themes using illustrative quotes.11 A
coding framework (online supplemental file 3) was developed deductively from study objectives to cover feasibility,
usability and acceptability as well as inductively from
emergent themes by the ETNA study team (M-LWK, VN,
DC, JR, JC, WM, ASG). VN conducted the primary coding
with review by M-LWK.
Data confidentiality was ensured through limiting
access of study materials to authorised personnel, deidentifying participants using codes, and aggregating demographic features.
Kinshella M-LW, et al. BMJ Open 2022;12:e053486. doi:10.1136/bmjopen-2021-053486

Patient and public involvement
Neither patients nor public were involved in the design or
conduct of the study.
RESULTS
Direct observations of HCP-D using the technologies on
12 neonates were made and IDIs conducted with 27 participants, including 5 HCA, 10 HCP-I (6 nurses, 2 clinical
officers and 2 physicians), 2 HCP-D (two study nurses,)
and 10 caregivers. No potential participants declined to
participate. Interviewed healthcare professionals were
woman except for one male clinician, and ranged in age
from 24 to 58 (average 36.2) years. With a median of 5
(range <1–35) years of work experience in the medical
field, approximately half (8 of 17) of the healthcare
professionals held diplomas or certificates as their highest
level of formal education. Four healthcare professionals
were pursuing a first degree or completed an undergraduate degree, while three held master degrees and
two had medical degrees. Interviewed caregivers were
woman ranging in age from 19 to 28 (average 22.3) years.
A majority reported that this was their first child (6 of
10 caregivers, range 1–3 children). Eight caregivers had
level education while two had primary-
level
secondary-
education. Most (8 of 10) caregivers reported they were
unemployed or a housewife, and two caregivers shared
that they were involved in informal, small-scale business.
Reported occupations of husbands and partners included
mason, mechanic, electrician, watchman, businessman,
marketing and driver.
Key themes reported regarding technology feasibility
included the number of neonates needing monitoring,
reliable access to electricity and computers, and cost
and maintenance implications of the MCPM technologies. Ease and efficiency of use, non-invasiveness and
portability were critical features highlighted for usability.
Supporting improved monitoring capacities, concerns
about radiation and electrical currents, and a need for
caregiver engagement were central themes noted for the
acceptability of the MCPM technologies.
Feasibility
Numbers of neonates to monitor
A major challenge at PMH was overcrowding, resulting in
the common practice of multiple neonates within a single
cot. As a HCA shared, ‘…we are admitting so many babies
but our capacity is low…the capacity of the unit is small
as compared to the neonates we receive and that is why
you find there are two-three-four babies in one-unit bed.’
(HCA, 1).
HCA and HCP posited that overcrowding impacted the
feasibility of scaling up individual MCPM technologies for
neonates, particularly the EarlySense technology which
is placed under the mattress. A study nurse said, ‘We've
not used [the EarlySense technology] where babies are
sharing the baby cot. …we don't know of its efficiency
when there’s more than one [baby]…’ (HCP-D, 1). A
3
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research consultant (VN, PhD in sociology, woman) and
two trained female research assistants (diplomas in health
sciences) who did not know participants prior to the study
activities were hired to conduct the IDIs with the enrolled
qualitative study participants and the direct observations
of the ETNA study nurses.
IDIs with HCA, HCP and caregivers and direct observations of HCP-D were conducted between 23 November
and 1 December 2020 following semistructured IDI
and structured observation guides. To investigate the
accuracy, reliability and performance of the technologies, IDIs included questions regarding reactions to
technology use, consideration of result trustworthiness,
advantages and concerns about each technology, local
health system constraints and suitability within their
facility (online supplemental file 1). While the focus of
the study is to understand the feasibility, usability and
acceptability of the investigational technologies, the
same questions were asked about all three technologies
to allow for contextualisation and comparison. Additionally, direct observations of HCP-D using the technologies
covered three different phases of usage for each of the
MCPM technologies: (1) technology preparation and
initial application; (2) ongoing technology monitoring
and troubleshooting; and (3) technology disconnection,
removal and cleaning (online supplemental file 2). Data
collection guides were developed for the ETNA qualitative study and piloted by the Kenyan data collection
team during training to refine questions. After obtaining
written informed consent, IDIs were conducted in person
in a quiet, private place within PMH in English or Kiswahili, the major local languages in Kenya, depending on
study participant preference. IDIs took between 18 and
78 min to conduct with an average length of 46.6 min.
Written informed consent was obtained from HCP-
D
for observations IDIs were audio-recorded with permission, field notes recorded during data collection, and no
repeat IDIs were conducted.

Open access

Reliable access to electricity and computers
While a back-up generator was available at PMH, HCA and
HCP reported that the generators were not always functional and frequently required repairs. Electrical outages
could lead to delays in using technologies that required
uninterrupted electricity supply, ‘If there is power failure
and a generator is faulty, we end up not doing what we
need until electricity is back’ (HCP-D, 2).
Unreliable electricity had direct implications for the
EarlySense technology, which was connected to wall
power. As one nurse said, ‘I saw [the EarlySense technology] is using power. So, if possible, can we have the
one without the power? So that if there is no electricity
we can still use it’ (HCP-I, 1). The Sibel technology used
a rechargeable battery, but HCP said that ensuring the
technology was fully charged when needed and charging
between electrical outages would be a challenge in a busy
neonatal unit. For example, a nurse said, ‘… unlike other
devices which you just connect to the (wall) socket and
they are ready to use, [the Sibel technology has] to be
prepared… So, charging them and making sure they
are ready for use is a challenge for a big hospital like
Pumwani’ (HCP-D, 2).
Additionally, both investigational technologies relied
on the use of external screens and computers, which
would require investments in equipment, spacing and
electrical infrastructure, and training for staff to use
along with the current manual documentation systems.
As a nurse said, ‘There’s no regular access to computer.
There’s only one, in in-charge office and… everything
else is manual’ (HCP-D, 1).
Cost and maintenance
Cost and maintenance implications of the MCPM technologies were also highlighted by HCA and HCP as critical factors influencing the feasibility of potential scale-up.
As a public hospital, HCA shared that PMH followed
4

the government procurement process, and while there
were a procurement and budget committee and a health
management board at PMH that took into account what
HCP needed in their department, the medical superintendent had to approve the purchase and the Kenya
Medical Supplies Authority did most of the purchasing.
Consequently, HCA said that a lack of funds at PMH to
purchase equipment is a challenge. HCA shared that
PMH was often reliant on donors and partners to fill in
the gaps, ‘not having funds for the equipment is a big
issue because money from the county or NMS (Nairobi
Metropolitan Services) is not available to us, and we have
to look for donors and partners who are able to procure
the equipment for us’ (HCA, 4). In addition to the initial
costs of purchasing the technology, there would be additional costs around maintenance. A HCA said, ‘…we
have to think through how we are going to maintain this
servicing. So there is a cost to it beyond the buying the
purchase’ (HCA, 3). Some wondered if replacement parts
and the training of local biomedical engineers to service
and repair the EarlySense and Sibel technologies were
available in the country. Taken together with funding
challenges for their initial purchase, ongoing maintenance could limit sustainable scale-up into routine care
as an ETNA study nurse observed, ‘I have seen sometimes
maybe… because of poor maintenance…it’s not effective
for as long as it should have been’ (HCP-D, 1).
Usability and acceptability
Direct observations of HCP-D using the MCPM technologies within the PMH neonatal unit supported usability with
appropriate availability of training and support. Similar
to the Masimo reference technology, application of the
EarlySense and Sibel technologies to a neonate each took
on average 5 min and the HCP-D were observed to not
face any difficulties with preparation, initial application,
monitoring, disconnection or cleaning. No use errors
where mistakes could potentially happen were observed
with either investigational technology. There was one
observation with each of the investigational technologies
where a HCP-D required assistance from another study
nurse to help calm an irritable neonate, which interfered
with technology readings (EarlySense) or application
(Sibel).
Ease and efficiency in use
Design factors shared by HCA and HCP that impacted
user experience included that the MCPM technologies
appeared easy to use and clean. Speaking of the EarlySense technology, a HCA said, ‘Looks easy to clean.
That is a big issue for us because we need to observe
high hygiene standards’ (HCA, 4). An ETNA study nurse
who used the technologies noted, ‘What I liked about
[the EarlySense technology] is that it’s easy to place. It’s
quite straightforward…’ (HCP-D, 1). A HCA said, ‘[The
Sibel technology] looks easy to use because you are just
attaching to the extremity and the trunk’ (HCA, 3). The
Kinshella M-LW, et al. BMJ Open 2022;12:e053486. doi:10.1136/bmjopen-2021-053486

BMJ Open: first published as 10.1136/bmjopen-2021-053486 on 11 January 2022. Downloaded from http://bmjopen.bmj.com/ on January 12, 2022 by guest. Protected by copyright.

HCA said that because the EarlySense technology ‘can
only take one [neonate], so it means for us we would have
to prioritize really who we have to monitor so that we give
them their space’ (HCA, 3). The EarlySense technology
was designed for each neonate to be in an individual cot
but healthcare professionals at PMH shared that this may
reduce the number of neonates that could be admitted
given the current practice of sharing cots.
The Sibel technology may better accommodate sharing
cots as one HCA highlighted, ‘sharing incubators, [the
Sibel technology] is comfortable to use. I like that it is
compact…’ (HCA, 4). However, overcrowding still had
implications for service delivery as different neonates
would need to be carefully identified and their readings
easily distinguishable from one another. As a clinical
officer said, A ‘challenge would be telling specifically this
is for this baby while you have 20 babies on this [Sibel
technology]. They will need to be sure that this belongs
to this baby in this room. They will need to have codes for
the specific baby…’ (HCP-I, 9).

Open access

Non-invasive but concerns about radiation and electrical currents
Additionally, the non-invasive design of the two investigational technologies was described by HCA, HCP and
caregivers to support user satisfaction because the MCPM
technologies did not appear to cause neonate discomfort. For example, a caregiver said of the EarlySense technology, ‘He will just sleep normally; it won’t affect him,
but all these [vital signs] shall be recorded so I think it will
be comfortable for him’ (CG, 4). An HCA noted, ‘when
I put [the EarlySense technology under] the mattress, it
won’t be inconvenient to the baby’ (HCA, 3). Similarly,
another caregiver said of the Sibel technology, ‘I like it
because the baby is comfortable when being placed on,
he is not crying, I just feel he is fine’ (CG, 3). An HCA
observed, ‘…[the Sibel technology are] such light gadgets
…they are not causing any undue pressure to the baby,
so they should be acceptable [to caregivers]’ (HCA, 3).
Kinshella M-LW, et al. BMJ Open 2022;12:e053486. doi:10.1136/bmjopen-2021-053486

In particular, respondents highlighted that the investigational technologies had no (EarlySense) or fewer (Sibel)
attachments. For example, an HCA said of the Sibel technology, ‘What I like about it is … it doesn’t have wires.
Wires bring complications’ (HCA, 2).
However, respondents shared that concerns about
radiation and electrical currents with wireless and Bluetooth technologies may reduce acceptability, particularly
among caregivers. A caregiver asked of the EarlySense
technology, ‘What I want to know is maybe, does it have
side effects because if it doesn’t touch him, how does it
monitor? Maybe [the EarlySense technology] can cause
radiation, cancer or something?’ (CG, 4). In reference to
the Sibel technology, a caregiver also spoke of ‘the fear
of transfer of dangerous waves to the body of the baby”
(CG, 7). An ETNA study nurse shared, ‘[The caregivers]
are concerned about the transfer of data from the Sibel
device, both limb and chest units, to the iPad… The main
concern is [that] Bluetooth uses radioactive material, so
how sure are we that these devices will not harm the baby?’
(HCP-D, 2). An HCA described that counselling may
be required to fully explain the MCPM technology and
dispel misconceptions, ‘…our population may wonder is
there some electrical current going through my baby’s
body… but if we take our time and explain, they wouldn’t
have a problem’ (HCA, 3).
HCA, HCP and caregivers emphasised the need for
caregiver counselling and engagement to support acceptability. Different caregivers may also react differently to
the use of MCPM technologies, so understanding caregiver perceptions was essential for appropriate engagement. For example, a physician said, ‘There are those who
worry extremely because when they see the gadgets on
the baby, they get worried. The other groups of patients
think that, the more gadgets there are, the better. What
is important is to explain to the mother and understand
their perception of what they are seeing’ (HCP-I, 7). A
nurse said, ‘I think they will like [the Sibel technology]
but still, it depends on how we communicate about it…I
believe with good communication, they will definitely
embrace it’ (HCP-I, 8).
Movement and portability
HCA and HCP shared that movement and portability
features could both support and/or hinder operating
the technology for its intended purpose. Both of the
investigational technologies were portable and could be
moved throughout the neonatal unit to where they were
needed. An HCA said, ‘I like the fact that [the EarlySense
technology] is a portable sized tool’ (HCA, 3). However,
while the EarlySense technology was portable, continuous
monitoring was interrupted if the neonate was not calm
or taken off the mattress for breastfeeding or other care
needs such as diaper changing or kangaroo mother care.
A nurse said of the EarlySense technology, ‘…it might
present a challenge when it is feeding time…. [Mothers]
will just come and take the baby off…’ (HCP-I, 9). An ETNA
study nurse said, ‘[The EarlySense technology] should
5
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investigational technologies were described as easy to use
for someone without extensive training.
Additionally, the MCPM technologies were described
as being able to efficiently collect multiple vital signs
within a single device. A clinical officer said of the EarlySense technology, ‘you will be able to collect most crucial
data… So you get a lot of data using a short time period’
(HCP-I, 4). Of the Sibel technology, a nurse observed,
‘…It is taking four vitals at the same time, whereas if it
is manual, I would have four gadgets…[such as] stethoscope, thermometers… Now that small gadget I just place
it on the chest…it is giving me all that and it is fast and
continuous…’ (HCP-I, 3). An ETNA study nurse said, ‘it
(Sibel) covers a lot of vital signs measurements, and yeah,
and almost as equivalent in functionality as the cardiac
monitor’ (HCP-D, 1).
The potential for the investigational technologies
to increase efficiency in monitoring was highlighted to
potentially extend clinical care capacity and reduce HCP
workload, which supported acceptability among healthcare professionals and caregivers. HCA and HCP emphasised the challenges of maintaining regular monitoring
in busy neonatal units where the number of HCP was
few in comparison to the number of neonates under
their care. Speaking about the EarlySense technology, a
nurse said, ‘This machine…is helping to ease the workload. Instead of placing one person to check on this baby
and the other baby—one person can assess and monitor
very many babies at a time because [the EarlySense technology] is doing all that work for him….[HCP] will be
positive about it’ (HCP-I, 3). A HCA noted that the Sibel
technology will be acceptable within their healthcare
facility because ‘I can leave the baby on something that
monitors them and have a central display screen about
the patients’ vitals in real time. Then the nurses will not
be as stretched taking the vitals on every single baby when
they are very few‘(HCA, 4). Caregivers also shared that the
investigational technologies would be acceptable to them
because the technologies improved monitoring and clinical follow-up of their neonates.

Open access

Comparison of the investigational and reference technologies
Like with the investigational technologies, a major challenge of feasibility for the Masimo Rad-
97 reference
technology was overcrowding in the PMH neonatal unit.
HCA and HCP highlighted that the stand-alone Masimo
Rad-97 unit required even more space than the investigational technologies, which compromised feasibility at
their facility. A nurse said, ‘We really get packed here …
I feel [the Masimo Rad-97 technology] will give us more
headaches because it needs more space… it will mean
that every room, maybe we may have two to three tables
to put it on …that will be a bit hectic’ (HCP-I, 8).
In contrast to the non-invasive design of the investigational technologies, HCA, HCP and caregivers highlighted that the Masimo Rad-97 technology had many
wires and tubes. More attachments to the neonate was
perceived to compromise neonate comfort and reduce
accuracy because neonate movement may dislodge a
connection, ‘Those many tubes, for babies who are a
little bit active, the jumpiness of the babies can alter one
or two things [and the] readings can be bad’ (HCA, 1).
The Masimo Rad-97 technology’s nasal cannula tubing
and wires were perceived by study respondents as invasive, interfering with the neonate’s movement and potentially increasing the risk of infection. For example, a HCA
said, ‘All foreign objects should be treated as infection
routes and I am not comfortable with that’ (HCA, 4). The
increased number of connections also intensified the
anticipated training necessary to use the Masimo Rad-97
technology properly. For example, a nurse said, ‘It has
a lot of connections and tubing. If somebody is not very
careful in the training, and you miss in connecting that
machine, you might miss the results…’ (HCP-I, 3).
In addition to usability concerns, there were also acceptability concerns with caregivers. The Masimo Rad-97 technology capnography feature was especially concerning
for mothers and their families as the capnography feature
was associated with oxygen therapy and worsening
neonate health conditions. An ETNA study nurse said,
‘It gives the picture of oxygen. Everyone knows when my
baby is on oxygen, s/he is very sick…The capnography
doesn't seem necessary especially for babies who are not
on oxygen because everyone’s speculations at first would
6

think you're administering oxygen’ (HCP-D, 1). Echoing
the ETNA study nurse’s statement, a caregiver said, ‘I
thought it was oxygen. He [the father] would panic…’
(CG, 2). Another caregiver said, ‘Especially the pipe that
goes to the nose. I would not want my child to be using
it… It makes you think that the child is in a very bad state’
(CG, 5).
However, while the Masimo Rad-97 technology capnography feature reduced acceptability among caregivers, its
familiarity in the neonatal unit may increase acceptability
among some HCP. For example, a nurse said, ‘if it’s just
something to insert on the nose, which is something we
are familiar with, so that one can be easy…’ (HCP-I, 5). An
ETNA study nurse said, ‘It’s familiar. It’s not a new device
on the ground, so it’s familiar to me and to most HCP’
(HCP-D, 1). Of the three technologies, 7 of 10 caregivers
rated EarlySense as the most preferable. There was more
diversity of responses among health professionals but
overall, the Sibel technology was most frequently favourably rated. Seven of 15 HCP who responded to the question rated the Sibel technology as their top choice among
the three technologies.
DISCUSSION
Design factors like non-invasiveness, portability, ease of
use and ability to measure multiple vital signs concurrently increased efficiency of care and supported the
usability and acceptability of the investigational technologies in neonates in this resource-
constrained setting.
Our study of two investigational neonatal MCPM techconstrained, high-
volume
nologies within a resource-
maternity hospital in sub-Saharan Africa highlighted how
locally appropriate technologies can support improved
neonatal care by expanding HCP capacity for monitoring
and increased efficiency to quickly respond to emerging
complications. Consequently, MCPM technologies can
play a valuable role in improving quality of neonatal
care as well as access, as more at-risk neonates are able
to be identified and prioritised for intensive care. Yet,
thoughtful user-friendly design factors cannot overcome
basic infrastructural gaps, the need for adequate and
trained HCP staffing to appropriately engage caregivers,
or negate the need for regular technology service and
support. Feasibility challenges of overcrowding and lack
of reliable electricity, and caregiver acceptability challenges such as mistrust of wireless features (investigational technologies) or fear of capnography (reference
Masimo Rad-97 technology), had implementation implications across all of the technologies within the study.
Currently, there are two reviews available of wearable continuous monitoring sensors for neonates, but
these only compiled existing products and their key
features.12 13 Acceptability and implementation factors
were not explored.12 13 The non-adoption, abandonment,
scale-up, spread and sustainability framework posits that
increasingly, complexity across seven domains (health
condition, technology, value, adopters, organisational
Kinshella M-LW, et al. BMJ Open 2022;12:e053486. doi:10.1136/bmjopen-2021-053486
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also not be used during resuscitation whereby there is a
lot of movement during chest compressions. This device
should be used only for calm babies…’ (HCP-D, 2).
The portable Sibel technology allowed for neonate
movement, as one nurse said, ‘It is light, easily portable,
and even with the movement of the baby, it won’t fall off.
[The Sibel technology] won’t give us inaccurate results
even with the movement of the baby’ (HCP-I, 8). However,
because of its small size and highly portable design characteristic, some worried that the Sibel technology may be
misplaced or stolen. An ETNA study nurse said, ‘They
are very small devices which can get lost easily’ (HCP-D,
2). Additionally, a HCA said, ‘[the Sibel technology is] so
portable and can be stolen.’(HCA, 2).
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concerns at AKUH. By contrast, all of these issues were
voiced as serious concerns among PMH study respondents. Overcrowding, unreliable electricity, lack of access
to computers and short staffing emerged as critical challenges to the feasibility of both the investigational and
reference MCPM technologies at PMH. The identification of the general level of infrastructure and human
resources are considered to be important in the development of technologies intended for use in low-income
and middle-
income countries (LMICs).5 The experience at PMH may be reflective of feasibility constraints
in other large public hospitals in sub-
Saharan Africa
where adequate human, equipment and infrastructural
resources have been identified as limiting factors in the
implementation of newborn health innovations.16 17 The
qualitative evaluations of the investigational MCPM technologies at two urban tertiary hospitals in Nairobi, Kenya
also highlighted that differences between LMICs healthcare settings may be just as important as those between
high-income countries and LMICs. In particular, findings
from our ETNA qualitative study support existing literature on the dramatically different hospital infrastructure
and human resources between private and public hospitals in Kenya,18 which has implications for the feasibility
of effective scale-up of neonatal technologies.
A limitation of the study included that only two respondents had direct experience with the investigational and
reference technologies; the HCP-I and HCA interviewed
did not. Though we did not find major differences in
themes reported between direct and indirect users,
there is a possibility that the HCP-
I interviewed may
shift responses given some direct experience with the
technologies. Additionally, the study was cross-sectional,
which captures findings within a specific point in time.
The qualitative study at PMH was conducted during the
COVID-19 pandemic and a healthcare worker strike in
Kenya, which may have impacted findings. Furthermore,
the qualitative approach was exploratory to identify
themes but the purposeful sampling design was limited
in its ability to quantify their representative frequency.
However, conducting IDIs with caregivers, HCP and
HCA allowed an expanded understanding of feasibility,
usability and acceptability from a wide range of perspectives. The triangulation of direct observations with IDIs
helped to strengthen reliability of findings, and the
comparison with qualitative research recently conducted
with a similar methodology and the same technologies in
another healthcare setting in Nairobi, Kenya helped to
deepen understanding of contextual factors.
CONCLUSIONS
MCPM technologies are an essential part of strengthening access to and quality of hospital-based neonatal
care. In moving from the need to assess multiple vital
signs individually and manually, MCPM technologies
have the potential to enable ongoing multiparameter clinical monitoring and improve efficiency in care
7
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capacity, wider system context and embedding/adaption over time) contributes to the non-
adoption of
novel health technologies.14 Addressing the first three
domains, MCPM technologies are standard in the care
of vulnerable neonates in high-resource health settings
and study participants in our low-resource health setting
valued their importance for improving quality of care and
expressed appreciation for user-friendly design features.
However, acceptability and systemic factors within their
organisational and infrastructural context emerged as
critical domains impacting capacity for scale-up, spread
and sustainability. Our study helps to fill the current gap
in understanding these domains for MCPM technologies
for neonates in resource-limited settings where they are
not yet routinely implemented.
In comparison to the qualitative evaluation of the
investigational technologies at AKUH (Ginsburg 2021),
a private, tertiary hospital in Nairobi, Kenya, there were
a number of similar usability and acceptability themes.
Potential harmful side effects from wireless connections
and mistrust of novel technologies were voiced as concerns
largely by caregivers at both hospitals. Similarly, the fears
regarding the novel technologies appeared to be alleviated among some caregivers with adequate HCP explanation. The concerns around electrical fields appeared to
cross socio-economic groups in Kenya as almost all of the
caregivers interviewed at AKUH had university education
and professional employment, compared with secondary
education and lack of employment outside of the home
for the majority of caregivers interviewed at PMH. Similar
design features were highlighted by respondents from
both PMH and AKUH to support usability of the investigational technologies, including their ease of use and
ability to measure multiple vital signs as well as concerns
about EarlySense technology monitoring disruptions
when neonates were restless or off the mattress. Trained
HCP at both hospitals were observed to effectively use the
investigational technologies without difficulties.
Additionally, caregivers at both hospitals disliked the
nasal capnography feature of the Masimo Rad-97 reference technology, which was associated with neonate
discomfort and fears around oxygen therapy. Both
AKUH and PMH groups mentioned that associations with
oxygen therapy made the situation seem more dire, as if
the neonate was critically ill. Caregiver anxiety around
nasal oxygen and tubing also have been reported with
other neonatal interventions such as bubble continuous
positive airway pressure in Malawi where oxygen therapies were associated with severe illness.15 HCP counselling was helpful to alleviate caregiver concerns in both
healthcare settings.
However, the context at AKUH was different than at
PMH. AKUH had a ratio of three neonates to a nurse,
reliable back-up electrical systems, a maintenance team
on staff and were less reliant on donor and partner
support to purchase new equipment. Consequently,
equipment costs, electrical outages, technology malfunction and maintenance were not emphasised as feasibility
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centrally monitored by HCP to ultimately improve health
outcomes and save lives. This has implications for overburdened clinical staff attempting to provide high-quality
neonatal care in resource-constrained healthcare settings.
Identification of more at-risk neonates through the use of
MCPM technologies also helps to improve access to the
care they may require. Overall, study participants were
positive about the usability of the investigational MCPM
technologies but highlighted implementation challenges
that require further consideration. New, innovative technologies need to be implemented within enabling environments. While thoughtful, user-friendly design factors
can support usability, technology on its own cannot overcome feasibility challenges of basic infrastructural gaps
and the continued need for adequate and trained staffing
to effectively engage caregivers and support quality
neonatal care. Innovative MCPM technologies have the
potential to significantly improve neonatal care in sub-
Saharan African healthcare facilities, but health system
strengthening is also critical to support their sustainable
uptake into routine care.

